Phase 1 study launches of novel CYP11A1 inhibitor for mCRPC
FDA authorizes Expanded Access Program of Anktiva for lymphopenia
Prostate cancer awareness in 2025: A human imperative in the wake of President Biden’s diagnosis
Pivotal trial of histotripsy system for kidney tumors reaches enrollment goal